The Procter & Gamble Company (NYSE:PG) Shares Sold by Payden & Rygel

Payden & Rygel cut its stake in The Procter & Gamble Company (NYSE:PG) by 40.1% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 104,380 shares of the company’s stock after selling 69,820 shares during the period. Payden & Rygel’s holdings in Procter & Gamble were worth $15,839,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently bought and sold shares of the stock. GW&K Investment Management LLC purchased a new position in shares of Procter & Gamble during the first quarter worth $28,000. Your Advocates Ltd. LLP raised its stake in shares of Procter & Gamble by 632.0% during the 2nd quarter. Your Advocates Ltd. LLP now owns 183 shares of the company’s stock valued at $28,000 after buying an additional 158 shares during the last quarter. Ten Capital Wealth Advisors LLC boosted its stake in shares of Procter & Gamble by 325.8% in the first quarter. Ten Capital Wealth Advisors LLC now owns 264 shares of the company’s stock worth $39,000 after buying an additional 202 shares during the last quarter. Wunderlich Capital Managemnt acquired a new stake in Procter & Gamble during the second quarter worth about $40,000. Finally, Silicon Valley Capital Partners raised its position in Procter & Gamble by 51.3% during the first quarter. Silicon Valley Capital Partners now owns 283 shares of the company’s stock valued at $42,000 after acquiring an additional 96 shares in the last quarter. Hedge funds and other institutional investors own 63.43% of the company’s stock.

Procter & Gamble Trading Down 1.2 %

NYSE:PG traded down $1.76 on Friday, hitting $151.07. The stock had a trading volume of 8,495,710 shares, compared to its average volume of 6,541,199. The company has a fifty day moving average price of $149.28 and a two-hundred day moving average price of $150.69. The stock has a market cap of $356.06 billion, a price-to-earnings ratio of 24.52, a PEG ratio of 3.16 and a beta of 0.47. The company has a quick ratio of 0.48, a current ratio of 0.67 and a debt-to-equity ratio of 0.51. The Procter & Gamble Company has a 1-year low of $135.83 and a 1-year high of $158.38.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Wednesday, October 18th. The company reported $1.83 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.12. Procter & Gamble had a return on equity of 33.49% and a net margin of 18.30%. The company had revenue of $21.87 billion during the quarter, compared to analyst estimates of $21.58 billion. During the same period in the prior year, the business posted $1.57 earnings per share. The firm’s revenue for the quarter was up 6.1% compared to the same quarter last year. Equities research analysts expect that The Procter & Gamble Company will post 6.42 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, November 15th. Shareholders of record on Friday, October 20th were paid a dividend of $0.9407 per share. This represents a $3.76 annualized dividend and a yield of 2.49%. The ex-dividend date was Thursday, October 19th. Procter & Gamble’s dividend payout ratio (DPR) is presently 61.04%.

Insider Buying and Selling at Procter & Gamble

In related news, CFO Andre Schulten sold 40,298 shares of the stock in a transaction that occurred on Monday, November 6th. The shares were sold at an average price of $150.61, for a total transaction of $6,069,281.78. Following the completion of the transaction, the chief financial officer now owns 36,460 shares of the company’s stock, valued at approximately $5,491,240.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CFO Andre Schulten sold 40,298 shares of the business’s stock in a transaction on Monday, November 6th. The stock was sold at an average price of $150.61, for a total value of $6,069,281.78. Following the sale, the chief financial officer now owns 36,460 shares in the company, valued at approximately $5,491,240.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO R. Alexandra Keith sold 19,661 shares of the firm’s stock in a transaction dated Tuesday, November 14th. The shares were sold at an average price of $153.47, for a total value of $3,017,373.67. Following the transaction, the chief executive officer now owns 24,438 shares of the company’s stock, valued at $3,750,499.86. The disclosure for this sale can be found here. Insiders sold a total of 96,088 shares of company stock worth $14,565,908 over the last three months. Insiders own 0.17% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on PG. Wells Fargo & Company lifted their target price on shares of Procter & Gamble from $160.00 to $162.00 and gave the company an “overweight” rating in a report on Thursday, October 19th. Barclays lowered their target price on shares of Procter & Gamble from $166.00 to $154.00 and set an “overweight” rating on the stock in a research note on Thursday, October 12th. DZ Bank raised Procter & Gamble from a “sell” rating to a “hold” rating and set a $155.00 price objective on the stock in a report on Friday, October 20th. William Blair began coverage on Procter & Gamble in a research note on Friday, September 8th. They set a “market perform” rating for the company. They noted that the move was a valuation call. Finally, Sanford C. Bernstein dropped their target price on shares of Procter & Gamble from $162.00 to $153.00 and set a “market perform” rating on the stock in a research report on Thursday, October 12th. Six equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $165.83.

Procter & Gamble Company Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.